Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.50 |
| ▸ | CTSB | P07858 | 2/20 | 0.50 |
| ▸ | CTSK | P43235 | 2/20 | 0.50 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.46 |
| ▸ | PSEN2 | P49810 | 4/20 | 0.46 |
| ▸ | APH1B | Q8WW43 | 4/20 | 0.46 |
| ▸ | NCSTN | Q92542 | 4/20 | 0.46 |
| ▸ | APH1A | Q96BI3 | 4/20 | 0.46 |
| ▸ | PSENEN | Q9NZ42 | 4/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.43 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.43 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1288390 | 0.85 | CYP3A4 (0.47) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL7985833 | 0.85 | CYP3A4 (0.47) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL28495921 | 0.84 | TSHR (0.45) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL25064813 | 0.81 | CTSL (0.42) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL28658333 | 0.81 | CTSL (0.42) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL3578653 | 0.81 | OPRM1 (0.39) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL416422 | 0.81 | OPRM1 (0.50) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL23050100 | 0.80 | CTSL (0.44) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL29132687 | 0.80 | CTSL (0.50) | CTSLCTSBCTSKPSEN1PSEN2 | |
| SCHEMBL582674 | 0.80 | CTSL (0.50) | CTSLCTSBCTSKPSEN1PSEN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-221619375-U | Material adding device for preparing 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118496070-A | Synthesis method of 3- (benzyloxy) -1-cyclobutanone | 武汉软件工程职业学院(武汉开放大学) | 2024-08-16 | — | — | CN | claimed |
| CN-115322106-B | Synthesis method of trans-3-azido-1-methylcyclobutanol and trans-3-amino-1-methylcyclobutanol | 沈阳药科大学 | 2023-08-15 | — | — | CN | claimed |
| CN-115322106-A | Synthesis method of trans-3-azido-1-methylcyclobutanol and trans-3-amino-1-methylcyclobutanol | 沈阳药科大学 | 2022-11-11 | — | — | CN | claimed |
| CN-113683493-B | Electron-rich conjugated diene compound, preparation method and application | 四川大学 | 2022-06-10 | — | — | CN | claimed |
| CN-111320535-B | Preparation method of 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-113683493-A | Electron-rich conjugated diene compound, preparation method and application | 四川大学 | 2021-11-23 | — | — | CN | claimed |
| CN-111320535-A | Preparation method of 3- (benzyloxy) -1-cyclobutanone | 苏州楚凯药业有限公司 | 2020-06-23 | — | — | CN | claimed |
| CN-103242152-B | The synthetic method of compound 3-(benzyloxy)-1-cyclobutanone | LANZHOU AGLI BIOCHEMICAL TECHNOLOGY CO., LTD. (CN) | 2015-12-02 | — | — | CN | claimed |
| CN-103242152-A | Method for synthesizing compound 3-(benzyloxy)-1-cyclobutanone | LANZHOU SHUYA BIOCHEMICAL TECHNOLOGY CO LTD | 2013-08-14 | — | — | CN | claimed |
| CN-122079984-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079983-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122079985-A | FGFR3 inhibitor compounds | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026098567-A1 | MACROCYCLIC COMPOUNDS AND USE THEREOF | 微境生物医药科技(上海)有限公司 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026098683-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | 盛睿泽华医药科技（苏州）有限公司 | 2026-05-15 | — | — | WO | disclosed |
| US-6040449-A | USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT | BANYU PHARMACEUTICAL CO LTD (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5948792-A | POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| WO-1999037644-A1 | TRIAZOLO-PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 1999-07-29 | — | — | WO | disclosed |
| EP-0930298-A1 | FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-07-21 | — | — | EP | disclosed |
| WO-1997028161-A1 | NOVEL PYRROLO[2,3-D]PYRIMIDINES AND THEIR USE AS TYROSINE KINASE INHIBITORS | NOVARTIS AG (CH) | 1997-08-07 | — | — | WO | disclosed |